Overexpression of HER-2/ErbB2 occurs in 20% of all breast cancer subtypes, and it can control processes such as cellular growth, apoptosis, proliferation, differentiation, angiogenesis, and invasion by regulating PI3K/AKT and MAPK/ERK signalling pathways [6]. Here, ERBB2 is linked to breast cancer.